DexCom revenue and financials
$86.90Change from previous close: +1.80%Absolute change: +$1.54
In the fiscal year ended December 2025, DexCom reported revenue of $4.66B (+15.60% year over year). Net income was $836.3M, a net margin of 17.9%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +15.60%
- 2025 vs 2024
- Net income growth
- +45.14%
- 2025 vs 2024
- Net margin
- 17.9%
- 2024: 14.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,441 | 990 | 749 | 670 | 443 | 476 | 315 | 123 | 92.0 | 56.2 |
| Depreciation and amortization | 252 | 218 | 186 | 156 | 102 | 67.1 | 48.7 | 29.1 | 16.1 | 15.0 |
| Capital expenditure | -364 | -359 | -237 | -365 | -389 | -199 | -180 | -67.1 | -66.0 | -55.7 |
| Investing cash flow | 536 | -208 | -507 | -522 | — | — | — | — | — | — |
| Financing cash flow | -1,686 | -735 | -319 | -553 | — | — | — | — | — | — |
| Share repurchases | -500 | -750 | -689 | -558 | 0.0 | 0.0 | 0.0 | -100 | 0.0 | 0.0 |
| Debt issued | 0.0 | 0.0 | 1,231 | 0.0 | — | — | — | — | — | — |
| Debt repaid | -1,208 | 0.0 | -787 | 0.0 | — | — | — | — | — | — |
| Effect of exchange rates | 21.5 | -7.4 | 1.5 | -5.8 | — | — | — | — | — | — |
| Net change in cash | 290 | 47.2 | -77.3 | -405 | — | — | — | — | — | — |
| Free cash flow | 1,077 | 631 | 512 | 305 | — | — | — | — | — | — |